Purpose
to determine the human safety of a new injectable antiretroviral agent for protential development and use as pre-exposure prophylaxis (PrEP)
Grantee
Division
Global Health
Date
NOVEMBER 2009
Region served
GLOBAL
Committed amount
$2,323,153
Grant topic
HIV
Duration (months)
55
Grantee location
London, United Kingdom
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.